From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Advice for Andrew Monk on how to be a spiv

By Tom Winnifrith | Friday 17 May 2019


Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I start with a comment on the amazing generosity of one person donating more than £11,000 to Rogue Bloggers for Woodlarks yesterday. It was not Neil Woodford though I did ask. Anyhow: to the 75% of you yet to donate think of me this weekend on a) my last training walk ahead of 33 miles next weekend and b) entertaining a visiting mother in law. As you think of my weekend, please donate HERE. In the podcast I discuss Woodford's latest bad news, Maistro (MAIS), Blur as was, UK Oil & Gas (UKOG) and Staffline (STAF). I also offer advice to Andrew Monk on which 1 AIM stock he should buy today for his mother's IHT Portfolio.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:58:16